The Ethical Landscape of Prodromal Parki...

In part two of this series, Drs. Shuvro Roy, Jiwon Oh, and Amit Bar-Or discuss the results of the FENhance 1 and 2 trials looking at fenebrutinib in relapsing MS. For more information, please read about the abstract that was presented at the 2026 AAN Annual Meeting. Read more abo ... Show More

In part one of this series, Drs. Shuvro Roy, Jiwon Oh, and Amit Bar-Or discuss the results of the fenebrutinib trial and highlight the key takeaways that healthcare providers should be aware of. For more information, please read about the abstract that was presented at the 2026 A ... Show More

In part one of this series, Dr. Halley Alexander and Dr. Heidi Munger Clary discuss the best methods for screening patients with epilepsy in a clinical setting. Show citations: Mula M, Brodie MJ, de Toffol B, et al. ILAE clinical practice recommendations for the medical treatment ... Show More

Dr. Jason Crowell talks with Dr. Colin Hoy about the concept of prodromal Parkinson disease and the ethical considerations surrounding its diagnosis. Read the related article in Neurology.  Disclosures can be found at Neurology.org. 

Dr. Matthew Barrett talks with Dr. Michael S. Okun about the caution and deliberation needed in understanding Parkinson disease biomarkers. Read the related viewpoint piece in JAMA Neurology. Disclosures can be found at Neurology.org. 

<p>Dr. Jason Crowell talks with Dr. Sophie Cho, Program Director in the Division of Clinical Research at NINDS, about the state of Parkinson disease research.</p> <p>For links to previous podcast episodes, please visit <a href="NPUb.org/Podcast">NPUb.org/Podcast</a>.</p> <p>Discl ... Show More

Dr. Jason Crowell talks with Dr. Daniel Garbin Di Luca about racial and ethnic differences in health-related quality of life for individuals with Parkinson disease. Read the related article in Neurology. For links to articles and previous podcast episodes, please visit NPUb.org/P ... Show More

Dr. Jeff Ratliff talks with Dr. Jason Margolesky about the frequency of blepharoclonus in Parkinson disease and atypical Parkinsonian disorders to explore whether this clinical phenomenology may be useful in the evaluation and diagnosis of patients with Parkinsonism. Read the rel ... Show More

<p>Dr. Jason Crowell talks with Prof. Haydeh Payami, Professor of Neurology and Genetics at the University of Alabama at Birmingham, about how the gut microbiome may play a role in Parkinson disease according to metagenomics.</p> <p><span data-sheets-value= "{"1":2,"2":"Dr. Gregg ... Show More

<p>In this episode I cover Parkinson&apos;s disease.<br/><br/>If you want to follow along with written notes on Parkinson&apos;s disease go to <a href='https://zerotofinals.com/medicine/neurology/parkinsons/'>https://zerotofinals.com/medicine/neurology/parkinsons/</a> or the neur ... Show More

Dr. Matt Barrett talks with Drs. Julie A. Schneider and Sonal Agrawal about whether Lewy body and cerebrovascular pathologies act synergistically to increase the severity of parkinsonism beyond their separate effects. Read the related article in Neurology. Visit NPUb.org/Podcast ... Show More

Dr. Jason Crowell talks with Dr. Subhojit Roy about a platform for investigating the role of serine-129 in synucleinopathies, with implications for drug development. Read the related article in the Neuron. Disclosures can be found at Neurology.org.